Chemistry:Tetrahydrocannabutol

From HandWiki
Short description: Chemical compound
Δ9-Tetrahydrocannabinol-C4
Tetrahydrocannabinol-c4.svg
THCB 3D BS.png
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC20H28O2
Molar mass300.442 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Δ9-Tetrahydrocannabutol (tetrahydrocannabinol-C4, THC-C4, Δ9-THCB, (C4)-Δ9-THC, butyl-THC) is a phytocannabinoid found in cannabis that is a homologue of tetrahydrocannabinol (THC), the main active component of Cannabis.[1] Structurally, they are only different by the pentyl side chain being replaced by a butyl side chain. THCB was studied by Roger Adams as early as 1942 [2]

Pharmacology

Δ9-THCB, showed an affinity for the human CB1 (Ki = 15 nM) and CB2 receptors (Ki = 51 nM) comparable to that of Δ9-THC.[1] The formalin test in vivo was performed on Δ9-THCB in order to reveal possible analgesic and anti-inflammatory properties.[1] The tetrad test in mice showed a partial agonistic activity of Δ9-THCB toward the CB1 receptor.[1] THCB has rarely been isolated from cannabis samples,[1][3] but appears to be less commonly present than THC or THCV. It is metabolized in a similar manner to THC.[4]

In an analysis by the University of Rhode Island on phytocannabinoids it was found that THC-Butyl had the highest 3C-like protease inhibitor activity against COVID-19 out of all the phytocannabinoids tested within that study but not as high as the antiviral drug GC376 (81% THCB vs 100% GC376).[5]

Chemistry

Similarly to THC, it has 7 double bond isomers and 30 stereoisomers.[6] The Δ8 isomer is known as a synthetic cannabinoid under the code name JWH-130,[7] and the ring-opened analogue cannibidibutol (CBDB) is also known.[8] THC-Butyl can be synthesized from 4-Butylresorcinol.

Cannabidibutol (CBDB), 60113-11-3 [1]
JWH-130 (Δ8-THCB), 51768-59-3 [2]

Legality

THCB is not scheduled internationally under the Convention on Psychotropic Substances, but may be controlled under analogue law in some individual jurisdictions as a homologue of THC.

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 "Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol". Journal of Natural Products 83 (1): 88–98. January 2020. doi:10.1021/acs.jnatprod.9b00876. PMID 31891265. 
  2. https://pubs.acs.org/doi/abs/10.1021/ja01255a061
  3. "Characterization of the butyl homologues of delta1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromatography and mass spectrometry". The Journal of Pharmacy and Pharmacology 28 (4): 280–285. April 1976. doi:10.1111/j.2042-7158.1976.tb04153.x. PMID 6715. 
  4. "In vivo metabolism of the n-butyl-homologues of delta 9-tetrahydrocannabinol and delta 8-tetrahydrocannabinol by the mouse". Xenobiotica; the Fate of Foreign Compounds in Biological Systems 18 (4): 417–427. April 1988. doi:10.3109/00498258809041678. PMID 2840781. 
  5. "Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity". Molecules 27 (18): 6127. September 2022. doi:10.3390/molecules27186127. PMID 36144858. 
  6. "Verschil THC Olie, CBD olie, wietolie, hennepolie en cannabisolie?". http://www.dutch-headshop.com/nl/verschil-thc-olie-cannabisolie-cbd-olie-wietolie-hennepolie-a-176.html. 
  7. "The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation". Perspectives in Medicinal Chemistry 8: 17–39. 2016. doi:10.4137/PMC.S32171. PMID 27398024. 
  8. "Phytocannabinoids: a unified critical inventory". Natural Product Reports 33 (12): 1357–1392. November 2016. doi:10.1039/c6np00074f. PMID 27722705.